Crossmark

High-dose quadrivalent influenza vaccine in older adults with or without cardiovascular risk: a meta-analysis of randomized trials on 511,890 participants

Crossref DOI link: https://doi.org/10.1186/s12979-026-00571-x

Published Online: 2026-05-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elgendy, Mohamed S. https://orcid.org/0000-0003-3080-2875
Shubietah, Abdalhakim https://orcid.org/0000-0002-8300-0262
Awashra, Ameer https://orcid.org/0009-0002-5122-8200
Rifai, Mohamed https://orcid.org/0009-0007-9457-9832
Qwaider, Mohanad https://orcid.org/0009-0002-2150-5772
Faheem, Mohamed A. https://orcid.org/0009-0009-0767-1070
Abuwatfa, Momin A. https://orcid.org/0009-0008-0132-6455
Ismayl, Mahmoud https://orcid.org/0000-0001-9033-7835
Alqadi, Mohammad https://orcid.org/0000-0001-6361-5692
License Information

Text and Data Mining valid from 2026-05-09

Version of Record valid from 2026-07-03
More Information

Article History

Received: 22 March 2026

Accepted: 5 May 2026

First Online: 9 May 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.